M. Yin
发表
T. Wagler,
Zhongmin Xu,
M. Kaufman,
2022,
Organic Process Research & Development.
N. Bodyak,
D. Gumerov,
Liuliang Qin,
2015,
Cancer research.
G. Baker,
M. Yin,
1999
.
D. Bergstrom,
M. Protopopova,
N. Bodyak,
2021,
Molecular Cancer Therapeutics.
D. Bergstrom,
M. Protopopova,
N. Bodyak,
2021,
Molecular Cancer Therapeutics.
A. Fischman,
M. Papisov,
S. Hillier,
2005,
Biomacromolecules.
A. Fischman,
M. Papisov,
N. Koshkina,
2005,
Molecular pharmaceutics.
A. Fischman,
M. Papisov,
A. Yurkovetskiy,
2004,
Molecular pharmaceutics.
A. Fischman,
M. Papisov,
Catherine D. McCusker,
2005,
Biomacromolecules.
D. Bergstrom,
N. Bodyak,
L. Poling,
2015
.
Guoxiong Yuan,
M. Huang,
Yingyan Jiang,
1999
.
Guoxiong Yuan,
M. Huang,
Yingyan Jiang,
1999
.
Mei-Yu Huang,
Guoxiong Yuan,
Mao-Ya Yin,
1999
.
Ting-Ting Jiang,
Guoxiong Yuan,
M. Huang,
2000
.
N. Bodyak,
D. Gumerov,
Liuliang Qin,
2022,
Bioorganic & medicinal chemistry letters.
Jalal T. Althakafy,
Abdullah K. Alanazi,
Chaolong Yang,
2022,
Advanced Composites and Hybrid Materials.
Abstract 754: Unique pharmacologic properties of Dolaflexin-based ADCs—a controlled bystander effect
D. Bergstrom,
M. Protopopova,
N. Bodyak,
2018,
Experimental and Molecular Therapeutics.
N. Bodyak,
L. Poling,
M. Devit,
2014
.
D. Bergstrom,
N. Bodyak,
L. Poling,
2016
.
Jeremy R. Duvall,
S. Collins,
Phonphimon Wongthida,
2023,
Molecular cancer therapeutics.